ArticleACS pharmacology & translational science2023

Preclinical Development of the Na-K-2Cl Co-transporter-1 (NKCC1) Inhibitor ARN23746 for the Treatment of Neurodevelopmental Disorders.

Annalisa Savardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.